Compare CHE & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHE | NOVT |
|---|---|---|
| Founded | 1970 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.0B |
| IPO Year | 1994 | 1999 |
| Metric | CHE | NOVT |
|---|---|---|
| Price | $532.25 | $142.55 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $501.50 | $144.00 |
| AVG Volume (30 Days) | 149.2K | ★ 439.2K |
| Earning Date | 04-23-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.57% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.84 | 0.51 |
| Revenue | ★ $2,529,978,000.00 | $521,290,000.00 |
| Revenue This Year | $6.56 | $8.61 |
| Revenue Next Year | $6.23 | $6.57 |
| P/E Ratio | ★ $110.26 | $273.27 |
| Revenue Growth | 4.06 | ★ 35.49 |
| 52 Week Low | $365.21 | $98.27 |
| 52 Week High | $551.68 | $171.85 |
| Indicator | CHE | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 72.73 | 45.27 |
| Support Level | $417.56 | $131.26 |
| Resistance Level | N/A | $149.42 |
| Average True Range (ATR) | 13.26 | 6.31 |
| MACD | 1.51 | -0.50 |
| Stochastic Oscillator | 72.40 | 36.62 |
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.